Aigen Investment Management LP lowered its stake in shares of Vital Farms, Inc. (NASDAQ:VITL – Free Report) by 37.7% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 7,063 shares of the company’s stock after selling 4,269 shares during the quarter. Aigen Investment Management LP’s holdings in Vital Farms were worth $266,000 at the end of the most recent reporting period.
Other large investors have also added to or reduced their stakes in the company. Nordea Investment Management AB acquired a new stake in Vital Farms during the fourth quarter worth approximately $2,765,000. JPMorgan Chase & Co. boosted its holdings in shares of Vital Farms by 38.9% in the 3rd quarter. JPMorgan Chase & Co. now owns 266,398 shares of the company’s stock valued at $9,343,000 after purchasing an additional 74,593 shares in the last quarter. Charles Schwab Investment Management Inc. boosted its holdings in shares of Vital Farms by 6.0% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 253,434 shares of the company’s stock valued at $8,888,000 after purchasing an additional 14,426 shares in the last quarter. Franklin Resources Inc. boosted its holdings in shares of Vital Farms by 10.2% in the 3rd quarter. Franklin Resources Inc. now owns 372,583 shares of the company’s stock valued at $13,066,000 after purchasing an additional 34,412 shares in the last quarter. Finally, Quest Partners LLC boosted its holdings in shares of Vital Farms by 882.6% in the 3rd quarter. Quest Partners LLC now owns 20,320 shares of the company’s stock valued at $713,000 after purchasing an additional 18,252 shares in the last quarter. Institutional investors and hedge funds own 98.59% of the company’s stock.
Analyst Ratings Changes
A number of brokerages have weighed in on VITL. Jefferies Financial Group reduced their target price on Vital Farms from $45.00 to $41.00 and set a “buy” rating on the stock in a report on Monday, November 11th. TD Cowen raised their target price on Vital Farms from $41.00 to $45.00 and gave the company a “buy” rating in a report on Wednesday, January 8th. Telsey Advisory Group reaffirmed an “outperform” rating and issued a $52.00 target price on shares of Vital Farms in a report on Friday, February 28th. Craig Hallum began coverage on Vital Farms in a report on Friday, December 20th. They issued a “buy” rating and a $50.00 target price on the stock. Finally, Stifel Nicolaus raised Vital Farms from a “hold” rating to a “buy” rating and set a $44.00 target price on the stock in a report on Friday, February 28th. Eight equities research analysts have rated the stock with a buy rating, According to data from MarketBeat, the company currently has an average rating of “Buy” and an average target price of $44.57.
Vital Farms Stock Up 9.0 %
Shares of VITL opened at $33.12 on Friday. Vital Farms, Inc. has a 52 week low of $20.66 and a 52 week high of $48.41. The stock has a market capitalization of $1.47 billion, a price-to-earnings ratio of 29.57 and a beta of 0.95. The company has a debt-to-equity ratio of 0.04, a quick ratio of 2.81 and a current ratio of 3.24. The stock has a fifty day moving average of $37.98 and a 200-day moving average of $35.70.
Vital Farms (NASDAQ:VITL – Get Free Report) last announced its earnings results on Thursday, February 27th. The company reported $0.23 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.15 by $0.08. The business had revenue of $165.99 million during the quarter, compared to analyst estimates of $160.32 million. Vital Farms had a return on equity of 22.29% and a net margin of 8.68%. As a group, sell-side analysts anticipate that Vital Farms, Inc. will post 1.11 earnings per share for the current fiscal year.
Insider Buying and Selling
In related news, insider Matthew Ohayer sold 24,000 shares of the firm’s stock in a transaction on Thursday, December 19th. The stock was sold at an average price of $38.19, for a total transaction of $916,560.00. Following the completion of the transaction, the insider now directly owns 7,038,890 shares of the company’s stock, valued at $268,815,209.10. This trade represents a 0.34 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Russell Diez-Canseco sold 44,728 shares of the firm’s stock in a transaction on Thursday, December 12th. The stock was sold at an average price of $37.66, for a total value of $1,684,456.48. Following the transaction, the chief executive officer now directly owns 613,797 shares of the company’s stock, valued at approximately $23,115,595.02. This represents a 6.79 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 190,202 shares of company stock valued at $7,855,957 in the last three months. Insiders own 27.60% of the company’s stock.
About Vital Farms
Vital Farms, Inc, a food company, provides pasture-raised products in the United States. It offers shell eggs, butter, hard-boiled eggs, and liquid whole eggs. The company was founded in 2007 and is headquartered in Austin, Texas.
Read More
- Five stocks we like better than Vital Farms
- What is the Dow Jones Industrial Average (DJIA)?
- These 4 Tech ETFs Just Hit 50-Day Lows—Time to Buy?
- 3 Ways To Invest In Coffee, Other Than Drinking It
- 3 Stocks to Buy While Others Stay on the Sidelines
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- MarketBeat Week in Review – 03/03 – 03/07
Want to see what other hedge funds are holding VITL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Vital Farms, Inc. (NASDAQ:VITL – Free Report).
Receive News & Ratings for Vital Farms Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vital Farms and related companies with MarketBeat.com's FREE daily email newsletter.